Industry Relations Council

HOPA's signature opportunity for industry support continues to be our Industry Relations Council (IRC), complete with benefits such as high visibility at conferences and events. Click here to learn more…

IRC participation is open to all organizations that support HOPA's mission and goals. Contact Laurie Rappa, Senior Development Manager at 877.467.2791 or lrappa@hoparx.org with inquiries.

Spacer Image

HOPA Annual Conference 2025

HOPA's Annual Conference 2025 will take place April 9-12 at the Oregon Convention Center in Portland, OR.
This conference is known for its late-breaking and diverse content delivered by oncology pharmacy professionals who are experts in optimizing care of patients with cancer and hematologic conditions. You can also count on AC25 to cover supportive care management and clinical practice updates on several disease states.

The 2024 Annual Conference saw over 1,500 registrations, offered 30 education sessions with 35 total CEs, 15 sponsored non-CE symposia, 11 sponsored CE symposia, and 56 exhibit booths.

In addition to all the great science delivered in plenary and breakout sessions, and presented in posters and abstracts, we also look forward to networking with members, colleagues, and industry partners like you.

Annual Conference Support Opportunities

Reserve your Early Bird Sponsorship Opportunities

Early Bird Opportunities for HOPA’s Annual Conference 2025 are available now!

Opportunities are available on a first come first served basis. If you're ready to get started, take a look at the early bird prospectus or complete the sponsorship form. Early bird pricing is only available until August 2.

Spacer Image conversation

HOPA Annual Conference 2025 Opportunities

Thank you for your interest in HOPA’s Annual Conference 2025. Our full 2025 prospectus will be available in September. It will provide you with information to get involved and get the attention of an important target audience.

We appreciate your considering these opportunities:

  • Become a conference sponsor
  • Promote your company and products in the Exhibit Hall
  • Present a CE or Non-CE Symposia
  • Be Visible – Check out in person and online advertising opportunities

Our annual conference in 2024 reached over 1,500 attendees with a wide range of sponsorship options including symposia and exhibits.

Spacer Image exhibit hall

View the Early Bird Prospectus

Click here for more information on early bird opportunities for HOPA's Annual Conference 2025.

Reserve your Early Bird 2025 Sponsorship Opportunities

Secure your company’s participation by August 2, 2024 to guarantee pricing.

View last year's Annual Conference 2024 prospectus

Please click here to view last year's Annual Conference 2024 prospectus.

Contact

If you have questions or would like to be added to the mailing list for the 2025 prospectus please contact the HOPA Development Team at development@hoparx.org.

grey

Evergreen Opportunities

Connect with HOPA Members in meaningful ways through our many events and opportunities. HOPA provides the latest, most pertinent information in the field. Our members are highly trained decision makers who are actively engaged in medication management and business decisions because of the distinctive demands and challenges of this specialized profession. HOPA is a unique organization that attracts a blend of clinicians, educators, researchers, and administrators and is committed to helping practitioners navigate the rapidly changing world of oncology practice. Our ongoing commitment to provide information to our members regularly reaches over 3,500 members through our print and digital resources.

Advertise with HOPA through our newsletters, eBlasts, mailing list rentals, and more.

The importance of industry support

HOPA's Time to Talk initiative

One example of what HOPA is able to achieve with a little bit of support is the Time to Talk Initiative.

Learn more about our past time to talk campaigns: Time to Talk Immuno-Oncology™ or CINV: Time to Talk Public Service Announcement for Adults 55+

HOPA's next Time to Talk campaign will focus on diversity in clinical trials.
If your company is interested in supporting this campaign reach out to development@hoparx.org for more information.

Rob Carauno testimonial about Time to Talk

Jeremy Whalen discussing Industry as a Career

HOPA Member, Jeremy Whalen, PharmD, BCOP, Medical Affairs Executive Director for Genentech discusses the intersection of a career in industry and his commitment to HOPA.